Skip to main content

Closed

CTNM: Contineum Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-27.0%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio37.17×

Contineum Therapeutics, Inc.

CTNMNASDAQ·USD·Closed

Contineum Therapeutics, Inc.

CTNMNASDAQ·USD·Closed

$15.49

−1.65%

$15.49

−$0.26 (1.65%)

52W Range

88thpctl

Volume

1.47×avg

Mkt Cap

579.11MUSD

P/E

-9.0TTM

Div Yield

–ann

52W Range

88thpctl

Volume

1.47×avg

Market Cap

579.11MUSD

P/E Ratio

-9.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings